Cargando…
Targeting epiregulin in the treatment-damaged tumor microenvironment restrains therapeutic resistance
The tumor microenvironment (TME) represents a milieu enabling cancer cells to develop malignant properties, while concerted interactions between cancer and stromal cells frequently shape an “activated/reprogramed” niche to accelerate pathological progression. Here we report that a soluble factor epi...
Autores principales: | Wang, Changxu, Long, Qilai, Fu, Qiang, Xu, Qixia, Fu, Da, Li, Yan, Gao, Libin, Guo, Jianming, Zhang, Xiaoling, Lam, Eric W.-F., Campisi, Judith, Sun, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630100/ https://www.ncbi.nlm.nih.gov/pubmed/36202915 http://dx.doi.org/10.1038/s41388-022-02476-7 |
Ejemplares similares
-
Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance
por: Chen, Fei, et al.
Publicado: (2018) -
Stress-Induced Neuroprotective Effects of Epiregulin and Amphiregulin
por: Zhan, Libin, et al.
Publicado: (2015) -
PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy
por: Dou, Xuefeng, et al.
Publicado: (2023) -
Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD‐L1)‐mediated immunosuppression
por: Xu, Qixia, et al.
Publicado: (2019) -
Epiregulin as a therapeutic target in non-small-cell lung cancer
por: Sunaga, Noriaki, et al.
Publicado: (2015)